FURIN and cystic fibrosis: We have further demonstrated that highly selective and potent inhibition of furin by a first-in-class cell-permeable compound (BOS-318) caused a sustained suppression of ENaC activity in CF AECs that resulted in increases in ASL height and mucociliary transport rates [54].